ACADIA Pharmaceuticals Inc (ACAD)
Solvency ratios
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | |
|---|---|---|---|---|---|
| Debt-to-assets ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt-to-capital ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt-to-equity ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial leverage ratio | 1.62 | 1.73 | 1.47 | 1.29 | 1.25 |
ACADIA Pharmaceuticals Inc has consistently maintained a strong solvency position over the years, as indicated by its debt-to-assets, debt-to-capital, and debt-to-equity ratios remaining at 0.00 for each year from 2020 to 2024. This suggests that the company has not relied heavily on debt to finance its operations and investments, resulting in a low level of financial leverage.
However, the financial leverage ratio has shown a slight increasing trend over the same period, rising from 1.25 in 2020 to 1.62 in 2024. While the financial leverage ratio is still at a moderate level, this increasing trend indicates that the company has been gradually using more debt in relation to its equity to fund its activities. This could imply a shift in the company's capital structure towards a slightly higher reliance on debt financing.
Overall, ACADIA Pharmaceuticals Inc's solvency ratios reflect a healthy financial position with low levels of debt relative to assets, capital, and equity. However, the increasing financial leverage ratio suggests a closer monitoring of the company's debt management practices may be warranted to ensure sustainable financial stability in the future.
Coverage ratios
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | |
|---|---|---|---|---|---|
| Interest coverage | — | — | -33.83 | -27.21 | -33.54 |
Interest coverage is a financial ratio used to assess a company's ability to cover its interest expenses with its earnings before interest and taxes (EBIT). A higher interest coverage ratio indicates a company is better positioned to meet its interest obligations. In the case of ACADIA Pharmaceuticals Inc, the interest coverage ratio has been consistently negative over the past few years, standing at -33.54 in December 31, 2020, -27.21 in December 31, 2021, and -33.83 in December 31, 2022. These figures suggest that the company's EBIT was not sufficient to cover its interest expenses during those periods. Moreover, data for December 31, 2023, and December 31, 2024, is not available in the provided dataset, making it difficult to assess any potential changes in the company's interest coverage ratio in those years. Overall, the negative trend in ACADIA Pharmaceuticals Inc's interest coverage ratio raises concerns about its ability to comfortably service its interest payments with its current earnings levels.